Tag: histone deacetylase inhibitors in cancer

Pancreatic cancer remains one of the most lethal malignancies, representing the third leading cause of cancer-related mortality in the United ...

In a groundbreaking advance that could reshape the future of oncology, researchers at Shandong University in Qingdao, China, have successfully ...

Abexinostat, a novel pan-histone deacetylase inhibitor, is emerging as a promising therapeutic agent for patients with relapsed or refractory B ...